SG Americas Securities LLC Raises Stake in Inspire Medical Systems, Inc. $INSP

SG Americas Securities LLC increased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 173.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,147 shares of the company’s stock after acquiring an additional 66,698 shares during the period. SG Americas Securities LLC’s holdings in Inspire Medical Systems were worth $5,423,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of INSP. Diversified Trust Co grew its holdings in Inspire Medical Systems by 40.7% in the first quarter. Diversified Trust Co now owns 11,867 shares of the company’s stock worth $612,000 after purchasing an additional 3,435 shares during the period. Rockefeller Capital Management L.P. lifted its holdings in shares of Inspire Medical Systems by 14.9% during the fourth quarter. Rockefeller Capital Management L.P. now owns 5,712 shares of the company’s stock valued at $527,000 after purchasing an additional 739 shares during the last quarter. Corient Private Wealth LLC bought a new stake in shares of Inspire Medical Systems in the 4th quarter worth approximately $354,000. Caitong International Asset Management Co. Ltd boosted its position in shares of Inspire Medical Systems by 291.9% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,233 shares of the company’s stock worth $390,000 after purchasing an additional 3,153 shares in the last quarter. Finally, Virtu Financial LLC boosted its position in shares of Inspire Medical Systems by 40.2% in the 4th quarter. Virtu Financial LLC now owns 5,712 shares of the company’s stock worth $527,000 after purchasing an additional 1,639 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on INSP shares. Piper Sandler lowered Inspire Medical Systems from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $85.00 to $55.00 in a research report on Tuesday, May 5th. JPMorgan Chase & Co. dropped their target price on Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Robert W. Baird cut their target price on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Weiss Ratings lowered Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 6th. Finally, Evercore lowered Inspire Medical Systems from an “outperform” rating to an “in-line” rating and set a $40.00 price target for the company. in a research report on Tuesday, June 23rd. Four equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, Inspire Medical Systems presently has a consensus rating of “Hold” and an average target price of $81.05.

Inspire Medical Systems Stock Down 0.2%

Shares of NYSE INSP opened at $45.65 on Monday. The firm has a market cap of $1.32 billion, a P/E ratio of 10.17, a PEG ratio of 4.63 and a beta of 0.73. Inspire Medical Systems, Inc. has a twelve month low of $38.91 and a twelve month high of $147.03. The company has a 50 day moving average of $45.52 and a 200 day moving average of $65.11.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Monday, May 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. The business had revenue of $204.58 million for the quarter, compared to the consensus estimate of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The company’s revenue was up 1.6% compared to the same quarter last year. During the same period last year, the business posted $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, equities analysts expect that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.